Dabur Pharma ANDA Approval for Carboplatin Molecule

Dabur Pharma Ltd has announced that the Company's Wholly Owned Subsidiary at United Kingdom, Dabur Oncology Plc has been granted ANDA approval for its Carboplatin molecule by USA FDA on September 29, 2006.

Source : Equity Bulls

Keywords